IGBA PROFILE

IGBA Statement at the Opening of the Sessions at the WIPO Assemblies (July 2024) Publications S T U D I E S A N D A C T I V I T I E S Gaming the System: An overview of originator companies' evergreening strategies used to hinder access to generic and biosimilar products (January 2025) INC-5 opening statement: Health industry support for a plastics instrument Joint Industry Statement for WHO’s Executive Board Meeting 156 (February 2025) IGBA position on Streamlined Development (2024) In Support of Global Comparator for Biosimilars—Waiving bridging studies concerning local versus global reference products (2024) O U R L A T E S T MORE INFORMATION For more details, regarding IGBA and its member associations, see the IGBA website at : WWW.IGBAMEDICINES.ORG